Healthcare provider profile · identity verified

Alison M Stanley, M.D.

Family Practice · LEOLA, PA · NPI 1629480371

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	380	111
Levothyroxine Sodium	Levothyroxine Sodium	283	76
Lisinopril	Lisinopril	241	68
Omeprazole	Omeprazole	218	67
Rosuvastatin Calcium	Rosuvastatin Calcium	198	55
Amlodipine Besylate	Amlodipine Besylate	174	57
Gabapentin	Gabapentin	164	36
Simvastatin	Simvastatin	139	37
Alprazolam	Alprazolam	132	28
Hydrochlorothiazide	Hydrochlorothiazide	131	43
Pantoprazole Sodium	Pantoprazole Sodium	112	33
Albuterol Sulfate Hfa	Albuterol Sulfate	105	36
Eliquis	Apixaban	103	24
Furosemide	Furosemide	103	33
Lorazepam	Lorazepam	102	26
Losartan Potassium	Losartan Potassium	102	29
Metoprolol Succinate	Metoprolol Succinate	102	31
Metformin Hcl	Metformin Hcl	96	31
Sertraline Hcl	Sertraline Hcl	93	25
Oxycodone Hcl	Oxycodone Hcl	87	16
Metoprolol Tartrate	Metoprolol Tartrate	85	26
Pravastatin Sodium	Pravastatin Sodium	84	22
Duloxetine Hcl	Duloxetine Hcl	81	19
Metformin Hcl Er	Metformin Hcl	80	23
Trazodone Hcl	Trazodone Hcl	75	26
Allopurinol	Allopurinol	59	18
Famotidine	Famotidine	59	21
Spironolactone	Spironolactone	59	12
Tamsulosin Hcl	Tamsulosin Hcl	58	17
Alendronate Sodium	Alendronate Sodium	56	18
Citalopram Hbr	Citalopram Hydrobromide	56	16
Ezetimibe	Ezetimibe	55	13
Prednisone	Prednisone	54	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	51	14
Jardiance	Empagliflozin	50	12
Ozempic	Semaglutide	50	13
Tizanidine Hcl	Tizanidine Hcl	50	17
Tramadol Hcl	Tramadol Hcl	49	18
Glipizide Er	Glipizide	47	15
Carvedilol	Carvedilol	46	13
Atenolol	Atenolol	43	14
Pregabalin	Pregabalin	43	11
Triamcinolone Acetonide	Triamcinolone Acetonide	42	28
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	40	suppressed
Diclofenac Sodium	Diclofenac Sodium	39	15
Fluticasone Propionate	Fluticasone Propionate	39	19
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Amoxicillin	Amoxicillin	37	33
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	36	14
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Bupropion Xl	Bupropion Hcl	35	11
Montelukast Sodium	Montelukast Sodium	33	11
Mirtazapine	Mirtazapine	31	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	29	suppressed
Glipizide	Glipizide	29	suppressed
Ipratropium Bromide	Ipratropium Bromide	29	13
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Benazepril Hcl	Benazepril Hcl	28	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	27	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Ondansetron Odt	Ondansetron	27	15
Morphine Sulfate Er	Morphine Sulfate	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Verapamil Er	Verapamil Hcl	26	suppressed
Clopidogrel	Clopidogrel Bisulfate	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	25	suppressed
Glimepiride	Glimepiride	24	suppressed
Valsartan	Valsartan	24	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	22	suppressed
Mounjaro	Tirzepatide	22	suppressed
Baclofen	Baclofen	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Diazepam	Diazepam	20	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Potassium Chloride	Potassium Chloride	20	suppressed
Terazosin Hcl	Terazosin Hcl	20	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	20	suppressed
Finasteride	Finasteride	19	suppressed
Ketoconazole	Ketoconazole	19	17
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Azithromycin	Azithromycin	16	16
Betamethasone Valerate	Betamethasone Valerate	16	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	16	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Mometasone Furoate	Mometasone Furoate	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Cefdinir	Cefdinir	14	13
Torsemide	Torsemide	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Eplerenone	Eplerenone	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Glyburide	Glyburide	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Symbicort	Budesonide/Formoterol Fumarate	11	suppressed
Tresiba Flextouch U-200	Insulin Degludec	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error